Cannabimimetic Activity in Rats and Pigeons of HU 210, a Potent Antiemetic Drug-Reference-Cited by-同舟云学术

Cannabimimetic Activity in Rats and Pigeons of HU 210, a Potent Antiemetic Drug

Published:1999-01 Issue:1 Volume:62 Page:75-80
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Ferrari F.,Ottani A.,Giuliani D.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference33 articles.

1. Effect of Δ9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes;Bloom;J. Pharmacol. Exp.Ther.,1982

2. Pharmacological profile of a series of bicyclic cannabinoid analogs;Compton;J. Pharmacol. Exp. Ther.,1992

3. Cannabinoid structure–activity relationship;Compton;J. Pharmacol Exp. Ther.,1993

4. Corticotropin-releasing factor (CRF) antagonist [D-PHE12, Nle21,38, CaMeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU 210 on defensive-withdrawal behavior in rats;De Fonseca;J. Pharmacol and Exp. Ther.,1996

5. Determination and characterization of a cannabinoid receptor in rat brain;Devane;Mol. Pharmacol.,1988

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An emerging trend in Novel Psychoactive Substances (NPSs): designer THC;Journal of Cannabis Research;2024-05-03

2. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective;Pharmacological Reports;2023-08-16

3. Should oncologists trust cannabinoids?;Frontiers in Pharmacology;2023-07-13

4. Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models;Behavioural Pharmacology;2022-01-17

5. Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators;Cannabis and Cannabinoid-Based Medicines in Cancer Care;2022